Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer
Clinical trial NCT04735068 · COMPLETED
Trial details
- NCT number
- NCT04735068
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-09
- Primary completion
- 2022-08-21
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.